E3 PreliminaryPreliminaryPEM unclearMethods-PaperPeer-reviewedMachine draft
RE: "MULTI-SITE CLINICAL ASSESSMENT OF MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (MCAM): DESIGN AND IMPLEMENTATION OF A PROSPECTIVE/RETROSPECTIVE ROLLING COHORT STUDY".
American journal of epidemiology · 2017 · DOI
Quick Summary
This study describes how researchers set up a large project to better understand and diagnose ME/CFS across multiple medical centers. The researchers created a system to carefully collect information about ME/CFS patients over time, combining both new patient data and information from medical records. This kind of organized approach helps scientists learn more about the condition and how to recognize it accurately.
Why It Matters
Standardized, multi-site clinical assessments are essential for establishing consistent diagnostic criteria and understanding disease heterogeneity in ME/CFS. This framework enables more rigorous research that could improve how clinicians identify and characterize ME/CFS, ultimately leading to better patient care and appropriate treatment strategies.
Observed Findings
- Multi-site coordination framework was successfully established for consistent ME/CFS assessment
- Standardized clinical protocols were implemented across participating centers
- A rolling cohort design was adopted allowing both prospective and retrospective data collection
- Systematic procedures were created for collecting comprehensive patient clinical and functional information
Inferred Conclusions
- Coordinated multi-site clinical assessment is feasible for ME/CFS research
- Standardized protocols can facilitate consistent data collection across different medical centers
- A hybrid prospective/retrospective approach can efficiently build large cohorts for ME/CFS investigation
Remaining Questions
- What specific biomarkers or clinical patterns emerge from the comprehensive data collected through this protocol?
- How do patient characteristics and disease presentations vary across different geographic and clinical sites?
- What diagnostic or prognostic value do the standardized assessments provide compared to routine clinical evaluation?
What This Study Does Not Prove
As a methods paper, this study does not prove the effectiveness of any treatment, establish diagnostic biomarkers, or provide evidence about ME/CFS causes. It does not demonstrate clinical outcomes or validate specific assessment tools—it only describes how the research will be conducted.
Tags
Method Flag:Exploratory Only
Metadata
- DOI
- 10.1093/aje/kwx119
- PMID
- 28535163
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 10 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →